Coverage
-
November 13, 2024
Vaccine developer Gritstone bio Inc. won a Delaware bankruptcy judge's approval Wednesday to borrow $25 million in new financing to support itself in Chapter 11 as the biotechnology company works to find a buyer.
3 other articles on this case.
View all »